 Connection
Thomas Henthorn to Hallucinogens
This is a "connection" page, showing publications Thomas Henthorn has written about Hallucinogens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.111 |
|
|
|
-
Sempio C, Huestis MA, Kaplan B, Klawitter J, Christians U, Henthorn TK. Urinary clearance of 11-nor-9-carboxy-?9 -tetrahydrocannabinol: A detailed pharmacokinetic analysis. Drug Test Anal. 2022 Aug; 14(8):1368-1376.
Score: 0.621
-
Kosnett MJ, Ma M, Dooley G, Wang GS, Friedman K, Brown T, Henthorn TK, Brooks-Russell A. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):355-362.
Score: 0.167
-
Rague JM, Ma M, Dooley G, Wang GS, Friedman K, Henthorn TK, Brooks-Russell A, Kosnett MJ. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):363-369.
Score: 0.166
-
Olofsen E, Kamp J, Henthorn TK, van Velzen M, Niesters M, Sarton E, Dahan A. Ketamine Psychedelic and Antinociceptive Effects Are Connected. Anesthesiology. 2022 05 01; 136(5):792-801.
Score: 0.156
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|